共查询到16条相似文献,搜索用时 156 毫秒
1.
2.
3.
4.
目的 探索胃癌发生过程的风险miRNAs,为上消化道机会性筛查中早期胃癌识别提供依据。方法 纳入2021年6月至2023年8月在广西医科大学附属肿瘤医院、右江民族医学院附属医院、桂林市人民医院3个中心进行上消化道癌机会性筛查的人群。选取健康体检者107例、早期胃癌患者71例、进展期胃癌患者97例。首先采用转录组测序筛选差异表达miRNAs,然后在3组前瞻性人群的血浆样本中通过RT-qPCR验证差异表达的miRNAs,最后采用受试者工作特征(receiver operating characteristic,ROC)曲线评估miRNAs的诊断效能。结果 转录组测序的差异基因分析共筛选出胃癌发生过程中的6个差异表达miRNAs,包括miR-3176、miR-885-5p、miR-203a-3p、miR-452-5p、miR-223-3p、miR-219a-2-3p。RT-qPCR结果显示,miR-452-5p在早期胃癌及进展期胃癌患者中表达上调(均P<0.001)。ROC曲线显示,miR-452-5p诊断早期胃癌和进展期胃癌的曲线下面积(area under the curve,AU... 相似文献
5.
目的:探索胃癌患者血清miR-17-92簇的表达水平,评价其对胃癌诊断和检测的临床应用价值.方法:qRT-PCR法检测79名胃癌患者及38名正常对照组中血清miR-17-92簇的表达水平.结果:miR-NAs可以在血清中稳定存在.血清miR-17-3p、miR-17-5p、miR-18a-5p、miR-19a-3p、miR-19b-3p、miR-20a-5p、miR-92a-3p的表达 水平在胃癌患者中均高于正常对照组(P=0.005、0.009、0.006、0.003、0.045、0.016).miR-17-3p 在七个miRNA中的ROC曲线下面积最大,且诊断的特异度高达89.00%.miR-17-3p和miR-19a-3p 联合检测对胃癌诊断特异度有明显提 高,高达94.70%,灵敏度为63.16%.miR-17-92簇的表达与胃癌的分期及淋巴结转移有关(P<0.01、=0.02).结论:血清miR-17-92簇可以作为一种潜在的胃癌生物标志物,辅助胃癌诊断. 相似文献
6.
目的 探讨外泌体微小RNA(miR)-133a在透明细胞肾细胞癌(ccRCC)中的表达及临床意义。方法 收集2015年9月至2019年1月在我院行根治性肾切除术的293例ccRCC患者的血清样本,另外收集200例健康体检者的血清样本作为对照组。提取血清及组织外泌体总RNA,采用TaqMan低密度芯片(TLDA)鉴定差异表达的miRNA,并通过实时荧光定量PCR(qPCR)进行验证。随访患者的总生存期(OS)和无病生存期(DFS)。结果 与健康对照组血清和癌旁正常组织比较,TLDA筛选得到3个在ccRCC患者血清外泌体和肿瘤组织中差异表达的miRNAs(miR-133a、miR-210、miR-7-1)。qPCR证实外泌体miR-133a表达在ccRCC患者中显著下调(P<0.001)。ccRCC患者外泌体miR-133a表达与肿瘤组织表达呈正相关(r=0.467,P<0.001)。受试者工作特征(ROC)曲线证实血清外泌体miR-133a诊断ccRCC曲线下面积(AUC)为0.78(95%CI:0.747~0.729)。术前血清外泌体miR-133a表达与TNM分期、Fuh... 相似文献
7.
8.
9.
目的 探讨胃癌患者血清外泌体粒径的变化及其在胃癌患者预后评估方面的临床意义。方法 收集2021年5月至2022年2月皖南医学院收治的胃癌病例,同时收集同期健康体检者作为对照组。采用PEG沉淀法提取32例胃癌患者及26例健康志愿者的血清外泌体,运用纳米颗粒跟踪技术(NTA)检测胃癌血清外泌体的粒径和浓度;分析血清外泌体粒径大小与胃癌临床病理特征的关系;采用受试者工作特征曲线(ROC)分析血清外泌体粒径和浓度检测对胃癌分期的预测价值。结果 胃癌患者血清外泌体的浓度为(9.53±6.24)×107particals/ml,高于健康对照组的(6.14±3.43)×107particals/ml,差异有统计学意义(P<0.05);且胃癌患者血清外泌体粒径为(108.35±16.63)nm,显著小于健康对照组的(128.23±20.24)nm,差异有统计学意义(P<0.001)。血清外泌体粒径与胃癌患者的分期相关,即随着胃癌分期的增加,血清外泌体的粒径显著下降(P<0.05);ROC曲线结果显示,血清外泌体粒径诊断胃癌的灵敏度、特异度分... 相似文献
10.
11.
Exosomal microRNAs (miRs/miRNAs) have been reported to be associated with cervical cancer. The aim of the present study was to investigate circulating exosomal miRNA as a biomarker for cervical cancer diagnosis. In the present study, samples from 6 patients with cervical cancer and 6 healthy control subjects were retrieved for exosomal RNA-sequencing. The results revealed that a total of 39 miRNAs were differentially expressed between patients with cervical cancer and healthy controls (P<0.001; fold-change >2.0). Exosomal miR-125a-5p was further quantified in plasma from 60 subjects, which included 22 healthy individuals and 38 patients with cervical cancer. miR-16a-5p served as the reference miRNA for quantitative PCR analysis of exosomal miR-125a-5p in patients with cervical cancer and healthy individuals. The results revealed that exosomal miR-125a-5p expression levels in the patients with cervical cancer were significantly lower than those in the healthy controls (P<0.001). Receiver operating characteristic (ROC) curve analyses were performed and the results revealed that the level of plasma exosomal miR-125a-5p was a potential marker for differentiating between non-cervical cancer and cervical cancer, with an ROC area under the curve of 0.7129. At the cut-off value of 2.537 for miR-125a-5p, cervical cancer diagnostic sensitivities and specificities were 59.1 and 84.2%, respectively. The present study provides confirmation that exosomal miR-125a-5p could potentially serve as a biomarker for cervical cancer diagnosis. The present study involved only a small number of clinical samples; more samples are required to support the conclusions of the present study. 相似文献
12.
13.
14.
Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer 下载免费PDF全文
Tahereh AzimiMahdi ParyanMahdieh Mondanizadeh Hossein SarmadianAshraf Zamani 《Asian Pacific journal of cancer prevention》2021,22(4):1271-1277
Background: one of the female-specific diseases with a high incidence and mortality is cervical cancer. The main cause of cervical cancer is infection with Human papilloma virus (HPV). Low-grade squamous intraepithelial lesions (LSIL) and High-grade squamous intraepithelial lesions (HSIL) usually is caused by an HPV infection. Considering the role of microRNAs (miRNAs) as diagnostic biomarkers for a variety of cancers, the aim of this study was to determine miR-92a-5p and miR-155-5p expression levels in LSIL and HSIL Pap Smear samples. Methods: After initial bioinformatic studies, A total of 75 samples (25 samples of patients with LSIL, 25 patients with HSIL and 25 healthy individuals) were subjected to RNA extraction and cDNA synthesis. The expressions levels of confirmed miRNAs in samples of patients with LSIL, HSIL and healthy individuals were evaluated by Real time PCR analysis. To demonstration the role of predicted miRNAs as novel biomarkers in diagnosis of LSIL and HSIL, ROC curve analysis was done. Results: Bioinformatics results showed that miR-92a-5p and miR-155-5p target the HPV E6 and E7 genes. The expression levels of these miRNAs were strikingly higher in Pap smear of patients with LSIL than in the healthy individuals (35.36, P = 0.001) (62.23, P = 0.001). Similarity, expression levels of miR-92a-5p and miR-155-5p were amazingly higher in patients with HSIL than in the healthy individuals (33.62, P= 0.001) (69.07, P= 0.001). Although, the levels of miR-92a-5p (0.95, P = 0. 85) and miR-155-5p (1.11, P = 0.84) exhibited no statistical differences between patients with LSIL and HSIL. Also, ROC curve analyses verified that miR-92a-5p and miR-155-5p are specific and sensitive and may serve as new biomarkers for the early detection of cervical cancer. Conclusion: These data suggest miR-92a-5p and miR-155-5p, which are upregulated in LSIL and HSIL, can be consider as predictive biomarkers for the prognosis of cervical cancer patients. 相似文献
15.
16.
Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers 下载免费PDF全文
A Rashid JusohSivanesan Vijaya MohanTan Lu PingTengku Ahmad Damitri Al Astani Bin Tengku DinJuhara Haron Roslini Che RomliHasnan JaafarSiti Norasikin NafiTuan Ismail Tuan SalwaniMaya Mazuwin Yahya 《Asian Pacific journal of cancer prevention》2021,22(5):1375-1381
Objective: This study aimed to characterize the miRNA expression profiles from plasma samples of our local breast cancer patients in comparison to healthy control by using miRNA PCR Array. Methods: In this study, plasma miRNA profiles from eight early-stage breast cancer patients and nine age-matched (± 2 years) healthy controls were characterized by miRNA array-based approach, followed by differential gene expression analysis, Independent T-test and construction of Receiver Operating Characteristic (ROC) curve to determine the capability of the assays to discriminate between breast cancer and the healthy control. Results: Based on the 372-miRNAs microarray profiling, a set of 40 differential miRNAs was extracted regarding to the fold change value at 2 and above. We further sub grouped 40 miRNAs of breast cancer patients that were significantly expressed at 2-fold change and higher. In this set, we discovered that 24 miRNAs were significantly upregulated and 16 miRNAs were significantly downregulated in breast cancer patients, as compared to the miRNA expression of healthy subjects. ROC curve analysis revealed that seven miRNAs (miR-125b-5p, miR-142-3p, miR-145-5p, miR-193a-5p, miR-27b-3p, miR-22-5p and miR-423-5p) had area under curve (AUC) value > 0.7 (AUC p-value < 0.05). Overlapping findings from differential gene expression analysis, ROC analysis, and Independent T-Test resulted in three miRNAs (miR-27b-3p, miR-22-5p, miR-145-5p). Cohen’s effect size for these three miRNAs was large with d value are more than 0.95. Conclusion: miR-27b-3p, miR-22-5p, miR-145-5p could be potential biomarkers to distinguish breast cancer patients from healthy controls. A validation study for these three miRNAs in an external set of samples is ongoing. 相似文献